Windlas Biotech Ltd's Nomination and Remuneration Committee meeting on August 24, 2025, approved the Windlas Plan 2025, clarifying that up to 2,09,590 stock units may be granted per employee per year, while maintaining the aggregate cap of 3,15,000 units. This amendment does not change the previously approved limits by shareholders.